Global Adenoids Market – Industry Trends and Forecast to 2030

Global Adenoids Market, By Stages (1st Degree, 2nd Degree, 3rd Degree, Others), Treatment (Medication, Surgery, Others), Route of Administration (Oral, Parenteral, Inhalational, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Adenoids Market Analysis and Size

The main factor for the growth of global adenoids market is increasing infection in tonsils and adenoid because of bacteria and viruses. Eradicating the adenoids glands causes no harm to the immune system of the body, instead, completely removing them works better for the immune response of the body. The surgical procedure is called adenoidectomy. People of any specific age can haves adenoidectomy; though, children are advised tonsillectomy to treat tonsillitis.

Data Bridge Market Research analyses a growth rate in the adenoids market in the forecast period 2022-2030. The expected CAGR of the adenoids market tends to be around 7% in the mentioned forecast period. The market was valued at USD 500 million in 2022, and it would grow up to USD 859.09 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Adenoids Market Scope and Segmentation

Market Definition

Adenoids consist of small pads of tissues which is located at the back of the throat and behind the nose, near eustachian tubes. They are nearly similar to tonsils which are located right above to adenoids. It fights or prevent infection and maintain body fluid. Adenoids usually shrink at the age of 5 years and vanish by the teenage periods. Occasionally adenoids increases when the infection is gone and become inflamed and painful. Symptoms associated with it include dry mouth, cracked lips, ear infection, runny nose, and restless sleep.

Global Adenoids Market Dynamics

Drivers

• Increasing Adoption of Surgeries

The growing adoption of surgeries is what increasing the growth of the market. A rise in the number of surgical procedures which is performed to remove tonsils & adenoids and an increase in the inclination towards technologically advanced products are most likely to enhance the global adenoid market during the forecast period 2023-2030.

• Increasing Demand for Oral Drugs

Oral drugs is anticipated to boost the market growth. Oral Drugs are easy to consume and thus is widely used in the elderly population. The segment is anticipated to increase the market as most products are widely available in different forms such as capsule and tablet, and, it is a very convenient route of administration.

Opportunities

• Rise in Sleep Apnea Disease

Increase in sleep apnea disorders can create different opportunities for the market growth. For instance, in 2017, as per the records of the Sleep Apnea Organization, an overall estimation of 22 million population in the U.S. had suffered from sleep apnea disorder. Tonsillectomy and adenoidectomy are the types of surgeries wherein these products are mostly used to treat disorders such as sleep apnea in children and snoring in adults. The most common cause of sleep apnea disorder among children is inflamed tonsils and adenoids in the upper airway. The increasing burden of sleep apnea disease enhances the market's growth.

• Increasing Healthcare Awareness

Health awareness amongst the population are increasing which leads in the prediction of drugs boost the market growth. The wide innovative launches in medications for the treatment of sleep apnea diseases are anticipated to boost the market simultaneously. Numerous researchers are investing in launching the drugs that increase the market growth. This creates more opportunity in the market.

Restraints/Challenges

• Dearth of Skilled Professionals

Lack of experienced healthcare professionals who are unaware of the different treatment methods associated with tonsils and adenoids disease could reduce the growth of the adenoids market during the forecast period.

• Risk associated with Surgeries

There are numerous risks that are associated with these surgeries that impede the market growth. Adenoidectomy has the same risks as other surgeries, such as anaesthetic reactions medication which is helpful in putting sleep during surgery can cause small side effects such as vomiting, headaches, nausea, and muscle soreness. Although long-term difficulties are uncommon, general anaesthesia does carry the risk of death. Swelling the tongue and soft palate can make breathing difficult, particularly in the first few hours after the procedure. Therefore, it hampers the market growth.

This adenoids market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adenoids market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Adenoids Market Scope

The adenoids market is segmented on the basis of stages, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• 1st Degree
• 2nd Degree
• 3rd Degree
• Others

Treatment

• Medication
• Surgery
• Others

Route of Administration

• Oral
• Parenteral
• Inhalational
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Adenoids Market Regional Analysis/Insights

The adenoids market is analysed and market size insights and trends are provided by stages, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the adenoids market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to have the highest market growth because of the high occurrence of numerous tonsils and adenoid infections and presence of generic manufacturers.

North America dominates the market due to advanced technology and the presence of key manufacturers. Europe is projected second largest market for adenoids because of the great advancement in field of tonsil & adenoid removal products and wide presence of trained professionals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Adenoids Market Share Analysis

The adenoids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to adenoids market.

Key players operating in the adenoids market include:

• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Cipla Inc. (U.S.)
• Abbott (U.S.)
• AbbVie Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Hikma Pharmaceuticals PLC (U.K.)
• Amneal Pharmaceuticals LLC. (U.S.)
• B. Braun SE (Germany)